Authors Date Title Country Type of publication Main topic
Barnett 2007 Minimizing metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidemia United Kingdom Consensus statement Second generation antipsychotics and metabolic problems
British Association of Psychopharmacology 2011 Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association of Psychopharmacology United Kingdom Consensus statement Management of antipsychotics
Chaudhry 2010 Management of physical health in patients with schizophrenia: international insights France, Spain, Germany, United Kingdom and Italy Consensus statement Physical health monitoring
Heald 2010 Management of physical health in patients with schizophrenia: practical recommendations Belgium, Spain, United Kingdom, United States Consensus statement Physical health monitoring
Ministry of Health Clinical
Practice Guidelines
Workgroup on
Schizophrenia
2011 Ministry of Health Clinical Practice Guidelines: Schizophrenia Singapore Clinical practice guideline Management of schizophrenia
NICE 2010 The NICE guidelines on core interventions on the treatment and management of schizophrenia in adults in primary and secondary care United Kingdom Clinical practice guideline based on systematic literature review Management of schizophrenia
Working Group of the Clinical Practice Guideline for Schizophrenia and Incipient Psychosis Disorder 2009 Clinical Practice Guidelines for Schizophrenia and Incipient Psychotic Disorder Spain Clinical practice guideline based on systematic literature review Management of schizophrenia and incipient psychotic disorder
Working Group on the Physical Health of Patients with Schizophrenia 2008 Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry Spain Consensus statement based on systematic literature review Physical health monitoring
Table 2: Comparison of guidelines and consensus statements on physical health and schizophrenia.